At a glance
ClinicalIndex Comparison RecordN/ACompleted· 127 enrolled
Drug / intervention
EZ-IOdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Determine the Safety of Continuous Intraosseous Vascular Access Over a Period of 48 Hours
In Brief
A clinical study evaluating EZ-IO for Intraosseous Vascular Access. Completed, enrolled 127 participants across 1 site.
Detailed Summary
A prospective study to determine the safety of intraosseous (IO) access for a period up to 48 hours in healthy adult volunteers and volunteers with a history of mild to moderate renal disease and/or controlled diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntraosseous Vascular Access
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMay 2013
Enrollment StartNov 2014
Primary CompletionJul 2016
TodayJul 2026
First PostedMay 31, 2013
Enrollment StartNov 1, 2014
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 13.1 years ago
Interventions
EZ-IOdevice
To have an EZ-IO placed up to 48 hours